Effects of Oxaliplatin Treatment on the Enteric Glial Cells and Neurons in the Mouse Ileum

Journal of Histochemistry and Cytochemistry

Volumn 64, Issue 9, 2016, Pages 530-545

  Robinson, Ainsley M ^a,b,c   Stojanovska, Vanesa ^a,b,c   Rahman, Ahmed A ^a,b,c   McQuade, Rachel M ^a,b,c   Senior, Paul V ^a,b,c   Nurgali, Kulmira ^a,b,c  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SUNSHINE HOSPITAL   (Australia)

Author keywords

chemotherapy; enteric glial cells; GFAP; myenteric and submucosal neurons; oxaliplatin; s100

Indexed keywords

BETA TUBULIN; GLIAL FIBRILLARY ACIDIC PROTEIN; OXALIPLATIN; PROTEIN; PROTEIN GENE PRODUCT 9.5; PROTEIN S100B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; OXIPLATIN; PLATINUM COMPLEX; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFECT; GANGLION; GENE PRODUCT; GLIA CELL; GOBLET CELL; ILEUM; IMMUNOREACTIVITY; IN VIVO STUDY; INTESTINE CELL; MALE; MOUSE; MYENTERIC PLEXUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBMUCOUS PLEXUS; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; GLIA; INNERVATION; METABOLISM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; GLIAL FIBRILLARY ACIDIC PROTEIN; ILEUM; MALE; MICE, INBRED BALB C; MYENTERIC PLEXUS; NEUROGLIA; NEURONS; ORGANOPLATINUM COMPOUNDS; PYRIDINES; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SUBMUCOUS PLEXUS;

EID: 84985991824     PISSN: 00221554     EISSN: 15515044     Source Type: Journal    
DOI: 10.1369/0022155416656842     Document Type: Article

References (67)

1. V.GolfinopoulosG.SalantiN.PavlidisJ.P.Ioannidis. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol. 2007;8:898–911.
2. J.CapdevilaE.ElezS.PeraltaT.MacarullaF.J.RamosJ.Tabernero. Oxaliplatin-based chemotherapy in the management of colorectal cancer. Exp Rev Anti-cancer Ther. 2008;8:1223–36.
3. S.BhushanH.McLeodC.M.Walko. Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer. Clin Colorectal Cancer. 2009;8:15–21.
4. R.M.Goldberg. Advances in the treatment of metastatic colorectal cancer. Oncologist. 2005;10:40–48.
5. M.C.KiernanA.V.Krishnan. The pathophysiology of oxaliplatin-induced neurotoxicity. Cur Med Chem. 2006;13:2901–7.
6. F.Di FioreE.Van Cutsem. Acute and long-term gastrointestinal consequences of chemotherapy. Best Prac Res Clin Gastroenterol. 2009;23:113–24.
7. T.AlcindorN.Beauger. Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol. 2011;18:18–25.
8. R.M.McQuadeJ.C.BornsteinK.Nurgali. Anti-colorectal cancer chemotherapy-induced diarrhoea: current treatments and side-effects. Int J Clin Med. 2014;5:393–406.
9. J.T.HartmannH.P.Lipp. Toxicity of platinum compounds. Exp Opin Pharmacother. 2003;4:889–901.
10. A.WeickhardtK.WellsW.Messersmith. Oxaliplatin-induced neuropathy in colorectal cancer. J Oncol. 2011;2011:1–7.
11. V.StojanovskaS.SakkalK.Nurgali. Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity. Am J Physiol. 2015;308:G223–32.
12. A.PiniR.GarellaE.IdrizajL.CalosiM.C.BaccariM.G.Vannucchi. Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. Neurogastroenterol Motil. 2016;28:206–16.
13. J.B.Furness. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9:286–4.
14. J.CabarrocasT.C.SavidgeR.S.Liblau. Role of enteric glial cells in inflammatory bowel disease. Glia. 2003;41:81–93.
15. A.RuhlY.NasserK.A.Sharkey. Enteric glia. Neurogastroenterol Motil. 2004;16:44–49.
16. A.Ruhl. Glial cells in the gut. Neurogastroenterol Motil. 2005;17:777–90.
17. G.Von BoyenM.Steinkamp. The enteric glia and neurotrophic factors. Gastroenterology. 2006;44:985–90.
18. G.Von BoyenM.SteinkampI.GeerlingM.ReinshagenK.H.SchaferG.AdlerJ.Kirsch. Proinflammatory cytokines induce neurotrophic factor expression in enteric glia: a key to the regulation of epithelial apoptosis in Crohn’s disease. Inflamm Bowel Dis. 2006;12:346–54.
19. M.NeunlistM.Rolli-DerkinderenR.LatorreL.Van LandeghemE.CoronP.DerkinderenR.De Giorgio. Enteric glial cells: recent developments and future directions. Gastroenterology. 2014;147:1230–7.
20. V.VasinaG.BarbaraL.TalamontiB.StanghelliniR.CorinaldesiM.ToniniF.De PontiR.De Giorgio. Enteric neuroplasticity evoked by inflammation. Auton Neurosci. 2006;126–127:264–72.
21. G.BassottiV.VillanacciG.CathomasC.A.MaurerS.FisogniM.CadeiL.BaronA.MorelliE.VallonciniB.Salerni. Enteric neuropathology of the terminal ileum in patients with intractable slow-transit constipation. Hum Pathol. 2006;37:1252–8.
22. G.BassottiV.VillanacciS.FisogniE.RossiP.BaronioC.ClericiC.A.MaurerG.CathomasE.Antonelli. Enteric glial cells and their role in gastrointestinal motor abnormalities: introducing the neuro-gliopathies. World J Gastroenterol. 2007;13:4035–41.
23. B.D.GulbransenK.A.Sharkey. Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2012;9:625–32.
24. 2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice. Gastroenterology. 2014;146:497–507.
25. G.IantornoG.BassottiZ.KoganC.M.LumiA.M.CabanneS.FisogniL.M.VarricaC.R.BilderJ.P.MunozB.LiserreA.MorelliV.Villanacci. The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol. 2007;31:460–68.
26. M.ThackerL.R.RiveraH.ChoJ.B.Furness. The relationship between glial distortion and neuronal changes following intestinal ischemia and reperfusion. Neurogastroenterol Motil. 2011;23:500–509.
27. G.EspositoC.CirilloG.SarnelliD.De FilippisF.P.D’ArmientoA.RoccoG.NardoneR.PetruzzelliM.GrossoP.IzzoT.IuvoneR.Cuomo. Enteric glial-derived s100β protein stimulates nitric oxide production in celiac disease. Gastroenterology. 2007;133:918–25.
28. C.CirilloG.SarnelliG.EspositoF.TurcoL.SteardoR.Cuomo. S100β protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. World J Gastroenterol. 2011;17:1261–6.
29. L.Di Cesare MannelliA.PaciniL.BonacciniM.ZanardelliT.MelloC.Ghelardini. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J Pain. 2013;14:1585–600.
30. J.ScholzC.J.Woolf. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–8.
31. Y.J.GaoR.R.Ji. Targeting astrocyte signalling for chronic pain. Neurotherapeutics. 2010;7:482–93.
32. L.Di Cesare MannelliA.PaciniL.MicheliA.TaniM.ZanardelliC.Ghelardini. Glial role in oxaliplatin-induced neuropathic pain. Exp Neurol. 2014;261:22–33.
33. G.VeraM.CastilloP.A.CabezosA.ChiarloneM.I.MartínA.GoriG.PasquinelliG.BarbaraV.StanghelliniR.CorinaldesiR.De GiorgioR.Abalo. Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterol Motil. 2011;23:370–8.
34. L.WafaiM.TaherV.JovanovskaJ.C.BornsteinC.R.DassK.Nurgali. Effects of oxaliplatin on mouse myenteric neurons and colonic motility. Front Neurosci. 2013;7:30.
35. S.Reagan-ShawM.NihalN.Ahmad. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659–61.
36. C.L.RennV.A.CarozziP.RheeD.GallopS.G.DorseyG.Cavaletti. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol Pain. 2011;7:29.
37. B.Rivero-GutiérrezA.AnzolaO.Martinez-AugustinD.SanchezdeF.Medina. Stain-free detection as loading control alternative to Ponceau and housekeeping protein immunodetection in Western blotting. Analyt Biochem. 2014;467:1–3.
38. W.BoesmansR.LasradoP.Vanden BergheV.Pachnis. Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system. Glia. 2015;63:229–41.
39. K.R.JessenR.Mirsky. Glial cells in the enteric nervous system contain glial fibrillary acidic protein. Nature. 1980;286:736–7.
40. L.F.EngR.S.GhirnikarY.L.Lee. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res. 2000;25:1439–51.
41. A.RuhlS.FranzkeW.Stremmel. IL-1beta and IL-10 have dual effects on enteric glial cell proliferation. Neurogastroenterol Motil. 2001;13:89–94.
42. C.CirilloG.SarnelliG.EspositoM.GrossoR.PetruzzelliP.IzzoG.CalF.P.D’ArmientoA.RoccoG.NardoneT.IuvoneL.SteardoR.Cuomo. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil. 2009;21:1209–12.
43. C.W.Heizmann. The multifunctional S100 protein family. Methods Mol Biol. 2002;172:69–80.
44. G.GabellaP.Trigg. Size of neurons and glial cells in the enteric ganglia of mice, guinea-pigs, rabbits and sheep. J Neurocytol. 1984;13:49–71.
45. C.RosenbaumM.A.SchickJ.WollbornA.HeiderC.-J.ScholzA.CecilB.NieslerJ.HirrlingerH.WallesM.Metzge. Activation of myenteric glia during acute inflammation in vitro and in vivo. PLoS ONE. 2016;11:e0151335.
46. A.C.AubeJ.CabarrocasJ.BauerD.PhilippeP.AubertF.DoulayR.LiblauJ.P.GalmicheM.Neunlist. Changes in enteric neuron phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut. 2006;55:630–37.
47. E.ColemanR.JuddL.HoeJ.DennisP.Posner. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia. 2004;48:166–78.
48. W.LiuW.YueR.Wu. Effects of diabetes on expression of glial fibrillary acidic protein and neurotrophins in rat colon. Auton Neurosci. 2010;154:79–83.
49. C.Stenkamp-StrahmS.PattersonJ.BorenM.GerickeO.Balemba. High-fat diet and age-dependent effects on enteric glial cell populations of mouse small intestine. Auton Neurosci. 2013;177:199–210.
50. N.L.Johnston-WilsonC.D.SimsJ.P.HofmannL.AndersonA.D.ShoreE.F.TorreyR.H.Yolken. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol Psychiatry. 2000;5:142–9.
51. D.TrioloG.DinaI.LorenzettiM.MalagutiP.MoranaU.Del CarroG.ComiA.MessingA.QuattriniS.C.Previtali. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci. 2006;1:3981–93.
52. D.R.MarshakS.A.PesceL.C.StanleyW.S.Griffin. Increased S100 beta neurotrophic activity in Alzheimer’s disease temporal lobe. Neurobiol Aging. 1992;13:1–7.
53. F.CaoX.F.YangW.G.LiuW.W.HuG.LiX.J.ZhengF.ShenX.ZhaoXqS.T.Lv. Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury. J Clin Neurosci. 2008;15:541–4.
54. B.K.KwonA.M.StammersL.M.BelangerA.BernardoD.ChanC.M.BishopG.P.SlobogeanH.ZhangH.UmedalyM.GiffinJ.StreetM.C.BoydS.J.PaquetteC.G.FisherM.F.Dvorak. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma. 2010;27:669–82.
55. Y.L.HuangM.DingH.A.Hansson. Dorsal root ganglion nerve cells transiently express increased immunoreactivity of the calcium-binding protein S-100β after sciatic nerve transection. Brain Res. 1998;785:351–4.
56. J.HuA.FerreiraL.J.Van Eldik. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem. 1997;69:2294–301.
57. E.T.TjwaJ.M.BradleyC.M.KeenanA.B.KroeseK.A.Sharkey. Interleukin-1beta activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon. Am J Physiol Gastrointest Liver Physiol. 2003;285:G1268–76.
58. D.M.Keefe. Mucositis management in patients with cancer. Support Cancer Ther. 2006;3:154–7.
59. L.PontellP.CastelucciM.BagyanszkiT.JovicM.ThackerK.NurgaliR.BronJ.B.Furness. Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. Virchows Archiv. 2009;455:55–65.
60. K.NurgaliZ.QuB.HunneM.ThackerL.PontellJ.B.Furness. Morphological and functional changes in the guinea-pig neurons projecting to the ileal mucosa at early stages after inflammatory damage. J Physiol. 2011;589:325–39.
61. K.NurgaliT.V.NguyenH.MatsuyamaM.ThackerH.L.RobbinsJ.B.Furness. Phenotypic changes of morphologically identified myenteric neurons following intestinal inflammation. J Physiol. 2007;583:593–609.
62. T.SugimotoA.TakeyamaM.FujitaH.IchikawaT.Takano-Yamamoto. Peripheral neuroglial death induced by cisplatin administration in newborn rats. Neuroreport. 2001;12:137–40.
63. K.JirsovaV.MandysW.H.GispenP.R.Bär. Cisplatin-induced apoptosis in cultures of human Schwann cells. Neurosci Lett. 2006;392:22–26.
64. L.E.TaL.EspesetJ.PodratzA.J.Windebank. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum–DNA binding. Neurotoxicology. 2006;27:992–1002.
65. A.ScuteriA.GalimbertiD.MaggioniM.RavasiS.PasiniG.NicoliniM.BossiM.MilosoG.CavalettiG.Tredici. Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology. 2009;30:312–9.
66. J.Jimenez-AndradeM.HerreraJ.GhilardiM.VardanyanO.MelemedjianP.Mantyh. Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies. Mol Pain. 2008;4:10.
67. E.S.McDonaldK.R.RandonA.KnightA.J.Windebank. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol Dis. 2005;18:305–13.